||
狼疮治疗再现曙光
https://paper.sciencenet.cn/htmlpaper/2019/12/2019122415415632954207.shtm
文献分析
http://www.pubmedplus.cn/P/SearchQuickResult?wd=3c4ee452-75f5-4940-b11a-5a121b0948a1
01. | 无法确认 | 8 篇 | 8.421% |
02. | 2022 | 9 篇 | 9.474% |
03. | 2021 | 21 篇 | 22.105% |
04. | 2020 | 23 篇 | 24.211% |
05. | 2019 | 5 篇 | 5.263% |
06. | 2018 | 13 篇 | 13.684% |
07. | 2017 | 8 篇 | 8.421% |
08. | 2016 | 2 篇 | 2.105% |
09. | 2015 | 3 篇 | 3.158% |
10. | 2014 | 1 篇 | 1.053% |
11. | 2013 | 1 篇 | 1.053% |
12. | 2006 | 1 篇 | 1.053% |
01. | ann rheum dis | 7 篇 | 7.368% |
02. | lupus sci med | 7 篇 | 7.368% |
03. | arthritis rheumatol | 6 篇 | 6.316% |
04. | lupus | 6 篇 | 6.316% |
05. | mabs | 4 篇 | 4.211% |
06. | n engl j med | 4 篇 | 4.211% |
07. | curr opin rheumatol | 3 篇 | 3.158% |
08. | int j mol sci | 3 篇 | 3.158% |
09. | mod rheumatol | 3 篇 | 3.158% |
10. | rheumatology (oxford) | 3 篇 | 3.158% |
01. | 美国 | 50 篇 | 52.632% |
02. | 瑞典 | 16 篇 | 16.842% |
03. | 英国 | 13 篇 | 13.684% |
04. | 澳大利亚 | 11 篇 | 11.579% |
05. | 法国 | 8 篇 | 8.421% |
06. | 德国 | 5 篇 | 5.263% |
07. | 日本 | 5 篇 | 5.263% |
08. | 比利时 | 3 篇 | 3.158% |
09. | 中国 | 2 篇 | 2.105% |
10. | 阿根廷 | 2 篇 | 2.105% |
01. | 中国长沙 | 1 篇 | 1.053% |
02. | 中国香港 | 1 篇 | 1.053% |
01. | Humans | 70 篇 | 73.684% |
02. | Lupus Erythematosus, Systemic | 55 篇 | 57.895% |
03. | Antibodies, Monoclonal, Humanized | 37 篇 | 38.947% |
04. | Antibodies, Monoclonal | 31 篇 | 32.632% |
05. | Treatment Outcome | 17 篇 | 17.895% |
06. | Immunosuppressive Agents | 15 篇 | 15.789% |
07. | Adult | 14 篇 | 14.737% |
08. | Male | 14 篇 | 14.737% |
09. | Female | 13 篇 | 13.684% |
10. | Receptor, Interferon alpha-beta | 12 篇 | 12.632% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-10-19 21:44
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社